Human medicines European Public Assessment Report (EPAR): Intanza, influenza vaccine (split virion, inactivated), Revision: 7, Authorised
Related Biotechnology, Pharmaceutical and Healthcare News
Human medicines European Public Assessment Report (EPAR): Pandemrix, influenza vaccine (H1N1)v (split virion, inactivated, adjuvanted) A/California/7/2009 (H1N1)v like strain (x-179a), Revision: 14, Authorised
Human medicines European Public Assessment Report (EPAR): Ixiaro, Japanese-encephalitis vaccine (inactivated, adsorbed), Revision: 4, Authorised
Human medicines European Public Assessment Report (EPAR): Ixiaro, Japanese encephalitis vaccine (inactivated, adsorbed), Revision: 4, Authorised
Human medicines European Public Assessment Report (EPAR): Menveo, meningococcal group A, C, W-135 and Y conjugate vaccine, Revision: 7, Authorised
Human medicines European Public Assessment Report (EPAR): Rotarix, rotavirus vaccine, live, attenuated, Revision: 10, Authorised
Original Article: Human medicines European Public Assessment Report (EPAR): Intanza, influenza vaccine (split virion, inactivated), Revision: 7, Authorised
NEXT ARTICLE
More From BioPortfolio on "Human medicines European Public Assessment Report (EPAR): Intanza, influenza vaccine (split virion, inactivated), Revision: 7, Authorised"
Search BioPortfolio:
